Home LiteratureArticle Details
PMID: 11049989 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.

Blood ·Vol. 96 ·No. 9 ·2000-11-01 ·Pages 3094-101

Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J

Abstract

The functional status of circulating human immunodeficiency (HIV)-specific CD8 T cells in chronically infected subjects was evaluated. By flow cytometry, only 5 of 7 subjects had detectable CD8 T cells that produced IFN-gamma after stimulation with HIV-infected primary CD4 T cells. In 2 subjects, the frequency of IFN-gamma-producing cells increased 4-fold when IL-2 was added to the culture medium; in another subject, IFN-gamma-producing cells could be detected only after IL-2 was added. IFN-gamma-producing cells ranged from 0.4% to 3% of CD8 T cells. Major histocompatibility complex-peptide tetramer staining, which identifies antigen-specific T cells irrespective of function, was used to evaluate the proportion of HIV-specific CD8 T cells that may be nonfunctional in vivo. CD8 T cells binding to tetramers complexed to HIV gag epitope SLYNTVATL and reverse transcriptase epitope YTAFTIPSI were identified in 9 of 15 and 5 of 12 HLA-A2-expressing seropositive subjects at frequencies of 0.1% to 1.1% and 0.1 to 0.7%, respectively. Freshly isolated tetramer-positive cells expressed a mixed pattern of memory and effector markers. On average, IFN-gamma was produced by less than 25% of tetramer-positive CD8 T cells after stimulation with the relevant gag or reverse transcriptase peptide. In all subjects tested, freshly isolated CD8 T cells were not cytolytic against peptide-pulsed B lymphoblastoid cell line or primary HIV-infected CD4 T-cell targets. Exposure to IL-2 enhanced the cytotoxicity of CD8 T cells against primary HIV-infected CD4 targets in 2 of 2 subjects tested. These results suggest that a significant proportion of HIV-specific CD8 T cells may be functionally compromised in vivo and that some function can be restored by exposure to IL-2.

MeSH Terms
Amino Acid Sequence CD4-Positive T-Lymphocytes/drug effects,immunology,virology CD8-Positive T-Lymphocytes/immunology,virology Cells, Cultured Chronic Disease Cytotoxicity, Immunologic Epitopes/immunology Flow Cytometry Gene Products, gag/chemistry,immunology HIV/immunology HIV Infections/blood,immunology HLA-A2 Antigen/blood Humans Interferon-gamma/biosynthesis Interleukin-2/pharmacology Kinetics Lymphocyte Activation
Chemicals
Epitopes Gene Products, gag HLA-A2 Antigen Interleukin-2 Interferon-gamma
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shankar P
Center for Blood Research, Harvard Medical School, and the New England Medical Center, Tufts University School of Medicine, Boston, MA, USA. shankar@cbr.med.harvard.edu
Russo M
Harnisch B
Patterson M
Skolnik P
Lieberman J
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2000-11-01
Pages
3094-101
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NIAID NIH HHS · R01AI45406 · United States
NIAID NIH HHS · R21AI45306 · United States
NIAID NIH HHS · R29AI38819 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com